Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 2,180,000 shares, a decline of 17.7% from the August 31st total of 2,650,000 shares. Based on an average trading volume of 189,900 shares, […]